Literature DB >> 20730659

Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease.

Alice B Kornblith1, Kristina Mirabeau-Beale, Hang Lee, Anne Kathryn Goodman, Richard T Penson, Lauren Pereira, Ursula A Matulonis.   

Abstract

This study described the long-term adjustment of 42 ovarian cancer survivors diagnosed with advanced-stage disease with no evidence of recurrence, a mean of 6.1 years postdiagnosis. 64% of survivors' mental health was at or above the norm of medical outpatients (Mental Health Inventory-17). No patients reported post-traumatic stress disorder at a diagnosable level (Post-Traumatic Stress Disorder (PTSD) Checklist-Civilian). The majority of survivors (> or = 75%) reported a positive impact of cancer on their lives (Impact of Cancer Scale) and excellent social support (Medical Outcomes Study Social Support Survey). However, a subset of survivors reported needing more help than was received regarding emotional problems (28.9%).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730659     DOI: 10.1080/07347332.2010.498458

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  13 in total

1.  A procedure for obtaining impact of cancer version 2 scores using version 1 responses.

Authors:  Catherine M Crespi; Patricia A Ganz; Laura Petersen; Sophia K Smith
Journal:  Qual Life Res       Date:  2013-02       Impact factor: 4.147

Review 2.  A systematic review of ovarian cancer and fear of recurrence.

Authors:  Melissa Ozga; Carol Aghajanian; Shannon Myers-Virtue; Glynnis McDonnell; Sabrina Jhanwar; Shira Hichenberg; Isabel Sulimanoff
Journal:  Palliat Support Care       Date:  2015-03-02

3.  Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach.

Authors:  Susan K Lutgendorf; Eileen Shinn; Jeanne Carter; Susan Leighton; Keith Baggerly; Michele Guindani; Bryan Fellman; Marianne Matzo; George M Slavich; Marc T Goodman; William Tew; Jenny Lester; Kathleen M Moore; Beth Y Karlan; Douglas A Levine; Anil K Sood
Journal:  Gynecol Oncol       Date:  2017-05-17       Impact factor: 5.482

4.  Traumatic stress in acute leukemia.

Authors:  Gary Rodin; Dora Yuen; Ashley Mischitelle; Mark D Minden; Joseph Brandwein; Aaron Schimmer; Charles Marmar; Lucia Gagliese; Christopher Lo; Anne Rydall; Camilla Zimmermann
Journal:  Psychooncology       Date:  2011-11-13       Impact factor: 3.894

5.  Problems Experienced by Ovarian Cancer Survivors During Treatment.

Authors:  Jessica Keim-Malpass; Shannon L Mihalko; Greg Russell; Doug Case; Brigitte Miller; Nancy E Avis
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2017-06-03

6.  Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers.

Authors:  Sharon Manne; Shannon Myers; Melissa Ozga; David Kissane; Debby Kashy; Stephen Rubin; Carolyn Heckman; Norm Rosenblum
Journal:  Gen Hosp Psychiatry       Date:  2013-10-09       Impact factor: 3.238

Review 7.  Ovarian cancer survivors' quality of life: a systematic review.

Authors:  D Ahmed-Lecheheb; F Joly
Journal:  J Cancer Surviv       Date:  2016-02-17       Impact factor: 4.442

8.  Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I.

Authors:  Yang Zhou; Melinda L Irwin; Leah M Ferrucci; Ruth McCorkle; Elizabeth A Ercolano; Fangyong Li; Kevin Stein; Brenda Cartmel
Journal:  Gynecol Oncol       Date:  2016-04-19       Impact factor: 5.482

Review 9.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

10.  Examining moderators of the relationship between social support and self-reported PTSD symptoms: A meta-analysis.

Authors:  Alyson K Zalta; Vanessa Tirone; Daria Orlowska; Rebecca K Blais; Ashton Lofgreen; Brian Klassen; Philip Held; Natalie R Stevens; Elizabeth Adkins; Amy L Dent
Journal:  Psychol Bull       Date:  2020-12-03       Impact factor: 17.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.